SCHEMBL624985

SCHEMBL624985

CC(C)(C)OC(=O)N1CCC(CNc2nn3cc(-c4cnc(N)c(C(F)(F)F)c4)nc3s2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
PIK3CA P42336 2/20 0.40
PRMT5 O14744 1/20 0.39
BCDIN3D Q7Z5W3 1/20 0.39
MAP3K12 Q12852 5/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SYK P43405 2/20 0.39
MAP4K1 Q92918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625128 0.88 CCNA2 (0.46) PIK3CAMAP3K12SYKMAP4K1GPR119
SCHEMBL626582 0.87 PIK3CA (0.42) MAPTPIK3CAMAP3K12PIK3CDPIK3CB
SCHEMBL625673 0.86 MAP3K12 (0.48) PIK3CAMAP3K12MAP4K1
SCHEMBL624984 0.86 PIK3CA (0.48) PIK3CA
SCHEMBL627611 0.84 MAP3K12 (0.43) PIK3CAMAP3K12PIK3CDPIK3CBPIK3CG
SCHEMBL628029 0.83 F2RL3 (0.49) KDM4EMAPTPRMT5HPGDMEN1
SCHEMBL626460 0.83 MAPT (0.46) KDM4EMAPTPRMT5HPGDMEN1
SCHEMBL624922 0.83 PIK3CA (0.42) PIK3CAMAP3K12MAP4K1GPR119
SCHEMBL626702 0.82 MAP3K12 (0.43) PIK3CAMAP3K12PIK3CDPIK3CBPIK3CG
SCHEMBL625408 0.82 MAP4K1 (0.39) PIK3CAMAP3K12SYKMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed